# RAG Benchmark — 2026-09-09

## Sonar Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=0 → 0 in context · 8192 ctx · emb 0.00s · gen 163.02s · total 166.8s_

_No chunks passed the similarity threshold._

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": ["Interviewer", "Participant"],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "Conservative mechanism-first review of the interview for cognitive biases. No retrieved scientific-paper passages were supplied, so candidate bias labels rely on general cognitive-science knowledge rather than corpus support."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_label": "Omission bias",
      "alternative_labels": ["Inaction bias", "Status quo bias"],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Discharge decision to withhold anticoagulation despite CHA2DS2-VASc 4 and HAS-BLED 2 favoring treatment",
      "supporting_interview_quote": "On day four, right before discharge, she had a small bruise where blood was drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for.",
      "plausible_mechanism": "A preference could be operating in which harm from commission, such as starting anticoagulation and causing bleeding, is treated as more concerning than harm from omission, such as withholding anticoagulation and leaving stroke risk untreated.",
      "why_not_identified": "The transcript does not affirmatively demonstrate a preference for inaction as a cognitive mechanism; the participant offers clinical reasons for deferring treatment—unexplained presyncope before a fall, borderline fall risk, and pending renal function—and explicitly states waiting was not felt to be inherently safer."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_label": "Ambiguity aversion",
      "alternative_labels": ["Uncertainty aversion"],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Initial decision to defer anticoagulation start date after new atrial fibrillation diagnosis",
      "supporting_interview_quote": "I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer.",
      "plausible_mechanism": "The participant may have favored delaying treatment because the clinical picture contained ambiguous or missing information, a pattern consistent with ambiguity aversion in which decision-makers avoid options with uncertain risks.",
      "why_not_identified": "The interview shows ordinary clinical uncertainty and a reasonable attempt to obtain missing information before acting; it does not clearly show that the participant disproportionately avoided ambiguity relative to known stroke risk."
    },
    {
      "candidate_id": "cand_003",
      "classification_status": "candidate",
      "proposed_bias_label": "Availability heuristic",
      "alternative_labels": ["Availability bias"],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Response to recent bleeding-complication case on the ward",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially.",
      "plausible_mechanism": "A recent, emotionally salient bleeding event could make anticoagulation-related bleeding more mentally available and thereby distort risk perception, even if the participant ultimately sought more information.",
      "why_not_identified": "The participant appears to recognize the comparison risk, checks objective details, and distinguishes the other patient's situation; there is no affirmative evidence that the salient bleeding case influenced the treatment timing or discharge decision."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "No retrieved scientific-paper passages were provided; candidate labels are based on general cognitive-science knowledge rather than corpus-derived definitions or diagnostic criteria.",
    "The transcript contains substantial clinical uncertainty, information gathering, and risk balancing; those features alone are not classified as cognitive biases under the requested conservative standard.",
    "No positive bias occurrence was identified because the participant did not clearly display a bias-specific mechanism affecting reasoning or action; the stated deferrals were tied to incomplete history, borderline fall risk, and pending renal function."
  ]
}

## Sonnet Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=0 → 0 in context · 8192 ctx · emb 0.00s · gen 166.95s · total 170.4s_

_No chunks passed the similarity threshold._

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": [
      "Interviewer",
      "Participant"
    ],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "Conservative mechanism-first review of the CTA transcript. No retrieved corpus passages were supplied, so no corpus-grounded support is used. Clinical uncertainty, incomplete information, and unstructured decision delay are not treated as bias unless a distinct bias-specific mechanism is affirmatively evidenced."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_label": "Omission bias",
      "alternative_labels": [],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Initial decision to defer anticoagulation despite stroke-risk scores favoring treatment",
      "supporting_interview_quote": "I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer.",
      "plausible_mechanism": "Preference for inaction over action could have contributed to deferring anticoagulation despite CHA2DS2-VASc 4 and HAS-BLED 2.",
      "why_not_identified": "The participant gives a clinical rationale based on an incomplete history and explicitly says the decision was not because waiting felt safer; ordinary uncertainty and incomplete workup are stronger non-bias explanations."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_label": "Availability heuristic",
      "alternative_labels": [
        "Availability bias",
        "Salience bias"
      ],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Influence of a nearby patient's bleeding complication on anticoagulation risk perception",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before.",
      "plausible_mechanism": "A vivid recent bleeding complication could increase the cognitive availability of bleeding risk and thereby increase caution about anticoagulation.",
      "why_not_identified": "The participant did not act on the story directly; he requested chart details, identified meaningful differences from his patient, and stated the comparison did not materially change treatment timing. There is no affirmative evidence that perceived risk was inflated or that this drove the final decision."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "No retrieved corpus passages were supplied, so corpus-based bias definitions and scientific grounding could not be used.",
    "The transcript reflects substantial clinical uncertainty, legitimate information gathering, and cautious decision-making; these are not treated as bias under the specified criteria."
  ]
}

## Gemini Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=0 → 0 in context · 8192 ctx · emb 0.00s · gen 130.27s · total 133.8s_

_No chunks passed the similarity threshold._

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": [
      "Interviewer",
      "Participant"
    ],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "Conservative mechanism-first review of a single retrospective CTA interview. No retrieved scientific corpus was supplied, so no corpus-derived labels or mechanisms were used."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_label": "omission bias",
      "alternative_labels": [
        "status quo bias",
        "inaction preference"
      ],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Anticoagulation initiation timing",
      "supporting_interview_quote": "I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer.",
      "plausible_mechanism": "Preferential weighting of harms caused by commission (starting anticoagulation and potentially causing bleeding) over harms caused by omission (withholding anticoagulation and risking stroke) could make deferral disproportionately attractive.",
      "why_not_identified": "The participant provides concrete clinical reasons for deferral, including unexplained pre-fall lightheadedness, borderline fall-risk assessment, and pending renal function, and there is no affirmative evidence that the risk/benefit weighting itself was distorted by action avoidance rather than explained by ordinary clinical uncertainty."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_label": "availability heuristic",
      "alternative_labels": [
        "affect heuristic"
      ],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Comparison with other patient bleeding complication",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before.",
      "plausible_mechanism": "A salient recent bleeding complication could increase the cognitive availability of anticoagulant-related bleeding, leading to overestimation of bleeding risk or heightened caution without a population-based probability update.",
      "why_not_identified": "The participant did not act on the salient comparator; instead, the resident was asked to retrieve details, and the participant then identified renal and antiplatelet differences that made the comparison inapplicable. No evidence shows the participant's probability or risk judgment was shifted by the salient case."
    },
    {
      "candidate_id": "cand_003",
      "classification_status": "candidate",
      "proposed_bias_label": "ambiguity aversion",
      "alternative_labels": [
        "uncertainty aversion"
      ],
      "taxonomy_status": "established_label",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Anticoagulation initiation under borderline fall risk and pending renal function",
      "supporting_interview_quote": "their answer was honestly that the literature doesn't give a clean threshold for a case like this.",
      "plausible_mechanism": "The combination of an unexplained pre-fall symptom, borderline fall-risk score, and unclear literature could make the decision set feel ambiguous, causing preference for inaction over a decision with known stroke-risk reduction.",
      "why_not_identified": "The participant explicitly weighed both stroke risk and bleeding risk, sought additional information, and identified pending renal function as a dosing obstacle. The transcript does not show disproportionate avoidance of ambiguity independent of legitimate clinical uncertainty."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "The analysis is based on retrospective participant self-report; actual implicit or transient biases may not be articulated or observable.",
    "No retrieved scientific corpus was supplied, so no corpus-derived labels, definitions, mechanisms, or metadata were available.",
    "Several plausible bias mechanisms were considered as candidates but did not meet the threshold for affirmative identification.",
    "Absence of affirmative bias evidence in this transcript does not establish that all reasoning was normatively optimal or free from bias."
  ]
}
